Marvell (MRVL) PT Raised to $29 at Cowen Following Cavium Deal; 'Organic Growth Plus Highly Synergistic Deal'
Tweet
Share
E-mail
Get Alerts MRVL Hot Sheet
Price: $244.25 +1.45%
Rating Summary:
49 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
49 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Cowen raised its price target on Marvell (NASDAQ: MRVL) to $29.00 (from $21.00) while maintaining a Outperform rating, following the company's recent announcement to acquire Cavium for $6 billion.
Analyst Karl Ackerman notes a positive outlook on the shares, following management's recent announcement to acquire Cavium for $6 billion, suggesting this transaction represents the next phase of the story to execution of $2 per share in EPS in 2019 with Cavium in place.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Downgrades Magna Intl (MG:CN) (MGA) to Market Perform
- Desjardins Reiterates Buy Rating on Cambria Gold Mines Inc (CAMB:CN)
- Polaris Industries (PII) PT Lowered to $61 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
